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Abstract 21 
The Kaposi's sarcoma-associated herpesvirus (KSHV) encoded immediate early gene, replication 22 
and transcription activator (K-Rta) is a key viral protein that serves as the master regulator for 23 
viral lytic replication. In this study, we investigated the role of K-Rta in cell cycle regulation and 24 
found that the expression of K-Rta in doxycycline (Dox)-inducible BJAB cells induced cell cycle 25 
arrest in G0/G1 phase. Western blot analysis of key cell cycle regulators revealed that K-Rta-26 
mediated cell cycle arrest was associated with a decrease in Cyclin A and phosphorylated Rb 27 
(pS807/ pS811) protein levels, both markers of S phase progression and an increase in protein 28 
levels for p27, a cyclin-dependent kinase inhibitor. Further, we found that K-Rta does not affect 29 
the transcription of p27 but regulates p27 at the post-translational level by inhibiting its 30 
proteosomal degradation. Immunofluorescence staining and cell fractionation experiments 31 
revealed largely nuclear compartmentalization of p27 in K-Rta expressing cells demonstrating 32 
that K-Rta not only stabilizes p27 but also modulates its cellular localization. Finally, shRNA 33 
knockdown of p27 significantly abrogates cell cycle arrest in K-Rta expressing cells supporting 34 
its key role in K-Rta mediated cell cycle arrest. Our findings are consistent with previous studies 35 
which showed that expression of immediate early genes of several herpes viruses including HSV, 36 
EBV and CMV results in cell cycle arrest at the G0/G1 phase, possibly to avoid competition of 37 
resources needed for host cell replication during the S phase.  38 
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Introduction 39 
.DSRVL¶VVDUFRPD-associated herpesvirus (KSHV), also known as Human herpesvirus-8 40 
(HHV-8) is a member of gammaherpesvirus family that includes Epstein Barr Virus (EBV), 41 
Herpesvirus saimiri (HVS) and Murid herpesvirus 68 (MHV 68) (1). KSHV is the etiological 42 
DJHQWRI.DSRVL¶VVDUFRPD.6, the most common tumor associated with HIV infection and for 43 
at least two other malignancies, pleural effusion lymphoma (PEL) DQGPXOWLFHQWULF&DVWOHPDQ¶V44 
disease (MCD) (2-4). Like all herpesviruses, the life cycle of KSHV consists of latent and lytic 45 
phases. The latent phase is characterized by a restricted pattern of viral gene expression that 46 
facilitates the evasion of immune surveillance and the establishment of lifelong persistent 47 
infection. The lytic phase drives the replication cycle and a majority of the viral genes are 48 
expressed in this phase. This phase mainly allows for the spread of the virus in the infected 49 
individual. A growing body of research suggests that both latent and lytic replication phases play 50 
an important role in the pathogenesis of KS (5). 51 
The transition from latency to lytic replication is controlled by the KSHV replication and 52 
transcription activator (K-Rta) gene, an immediately early gene encoded by open reading frame 53 
50 (ORF50). K-Rta expression has been found to be essential and sufficient to trigger lytic 54 
replication by activating the lytic gene expression cascade (6-8). Genetic knockout of K-Rta 55 
resulted in a null phenotype in viral DNA synthesis and in virus production (9). K-Rta is a 691-56 
amino acid (aa) long transcriptional factor that contains an N-terminal DNA-binding domain and 57 
a C-terminal activation domain. K-Rta can trigger KSHV lytic reactivation via transcriptional 58 
activation of a number of viral lytic promoters, by either binding directly to the promoter DNA 59 
or indirectly via interaction with cellular DNA binding proteins (10-15).  60 
There is a complex interplay between herpesvirus lytic replication and host cell cycle 61 
arrest. Previous studies investigating the role of cell cycle in herpesvirus lytic replication 62 
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suggested that host cell cycle arrest precedes the induction of lytic cycle and essentially 63 
determines whether immediate early gene expression is initiated or not (16). However, current 64 
research increasingly support the idea that cell cycle arrest follows lytic cycle induction and is a 65 
direct consequence of immediate early gene expression (17-19). It is hypothesized that arresting 66 
cells during early lytic replication may be an evolutionary common strategy employed by 67 
herpesviruses to avoid competition of resources required for viral DNA replication with the host 68 
in the S phase, or it may serve to prevent premature apoptosis during lytic replication (20). This 69 
is in contrast to small DNA viruses, especially those lacking their own polymerase like SV40 and 70 
adenoviruses which actively drive host cells into S phase of the cell cycle in order to replicate 71 
their genome at the same time with host DNA synthesis. Arresting cell growth early during 72 
infection/reactivation may also be a strategy to avoid being killed by cytotoxic T cells as it has 73 
been reported that non-cycling cells are refractory to killing by cytotoxic T cells (21).  74 
To date, several herpesvirus-encoded proteins have been identified that participate in 75 
arresting host cell growth. These proteins are either virion components and/or immediate early 76 
(IE) transcriptional factors. For example, the IE product of herpes simplex virus, ICPO has been 77 
found to arrest cell cycle in G1 phase by both p53 mediated and p53 independent pathways (22, 78 
23) . In the case of EBV, immediate early product, Zta can induce host cell cycle arrest by 79 
stabilizing p53 and p27, and also through repressing the expression of c-myc (24, 25). 80 
Furthermore it has been shown that Zta may cooperate with host transcriptional factor C/EBP to 81 
upregulate p21, which in turn results in cell cycle arrest (26).  82 
Among the characterized early genes of KSHV, K8 or K-bZIP protein, a functional 83 
KRPRORJXHRI(%9¶VLPPHGLDWHHDUO\=WD protein was shown to arrest PEL cells in G1 phase 84 
during lytic cycle by up regulating C/EBP and p21 proteins (27). K8 was also found to inhibit 85 
kinase activities of CDK2 by directly binding through its bZIP domain (17). However the role of 86 
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KSHV encoded ORF50/K-Rta, one of the first genes transcribed and the central regulator for the 87 
initiation of lytic replication cycle, in cell cycle regulation has not been evaluated. In the present 88 
study, we demonstrated that K-Rta induces cell cycle arrest in an inducible BJAB cell model and 89 
this growth arrest is mediated by elevated levels of p27, a central cyclin-dependent kinase 90 
inhibitor (CDKI). Our results shed new light on the biological function of K-Rta as a key cell 91 
cycle regulator early on during viral reactivation, in addition to being a transcriptional regulator. 92 
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Mater ials and Methods 93 
Cell culture plasmids and transfection. 293T cells, 293 based doxycycline-inducible K-Rta 94 
cell line (TREx293Rta) (provided Dr Yoshihiro Izumiya, University of California at Davis, 95 
California) and Vero cells ZHUHFXOWXUHGLQ'XOEHFFR¶VPRGLILHG(DJOH¶VPHGLXP'0(096 
Invitrogen, Carlsbad CA) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, 97 
UT) and 100 µg/ml penicillin-streptomycin (Mediatech). DG75 is an EBV-negative Burkitt's 98 
lymphoma (BL) derived B-cell line (provided by Dr. Luwen Zhang, University of Nebraska-99 
Lincoln, Lincoln NE). It was grown in RPMI 1640 medium (Gibco BRL) supplemented with 100 
10% FBS and 100 µg/ml penicillin-streptomycin. TRExBJABRta and TRExBJAB cells are 101 
BJAB (EBV and KSHV negative B-cell line) derived cell lines with or without doxycycline-102 
inducible K-Rta gene. They were provided by Dr Jae Jung (University of Southern California, 103 
Los Angeles, CA) (28) and were grown in RPMI 1640 medium supplemented with 10% FBS, 104 
100 µg/ml penicillin-streptomycin and 200 µg/ml of hygromycin B. KSHV-positive and EBV-105 
negative B cell lines, BC3 cells (ATCC, USA) and Cro6 (29) (provided by Dr. Luwen Zhang, 106 
University of Nebraska-Lincoln, Lincoln NE) were grown in RPMI 1640 medium (ATCC, USA) 107 
supplemented with 20% FBS and 100 µg/ml penicillin-streptomycin. Human Microvascular 108 
Endothelial Cells (HMVEC) cells were grown in endothelial basal medium-2 (EBM-2) (Lonza, 109 
Boston, MA) supplemented with 10% fetal bovine serum (FBS), 100 µg/ml penicillin-110 
VWUHSWRP\FLQȝJPOHSLGHUPDOJURZWKIDFWRUDQGȝJPOK\GURFRUWLsone (30). All cultures 111 
were incubated at 37°C with 5% CO2. 112 
K-Rta expression plasmid (pCMVtagORF50), which encodes Flag-tagged full length Rta 113 
and pCMVtagORF50 (1-527), which encodes truncated K-Rta (amino acid 1 to 527), were 114 
described previously (31). The transfection of 293T cells and Vero cells was carried out using 115 
Lipofectamine 2000 (Invitrogen) or Fugene 6 (Promega) DFFRUGLQJWRWKHPDQXIDFWXUHU¶V116 
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recommendations. The transfection of DG75 was carried out using the nucleofection protocol 117 
DFFRUGLQJWRWKHPDQXIDFWXUHU¶Vprotocols (Solution V and program O-006, Amaxa Biosystems). 118 
Cell Cycle analysis. Cell cycle profiles were analyzed by flow cytometry with standard 119 
propidium iodide (PI) staining methods (32). Asynchronized and synchronized cells were 120 
harvested at given time points, washed once with PBS and fixed in 70% ethanol at -20°C. After 121 
collection of all time points, the cells were washed with PBS twice and were resuspended in PBS 122 
containing PI (Roche) DWDILQDOFRQFHQWUDWLRQRIȝJPODQGRNase $ȝJPO7KHVDPSOHV123 
were kept at RT for 30 min in dark and 20,000 events per sample were acquired using FACS 124 
Calibur flow cytometer (BD Biosciences). The data was analyzed using Modfit LT version 2.0 125 
software (Verity Software House Inc.).  126 
RNA extraction and RT-PCR. Total cellular RNA was extracted using an RNeasy kit 127 
4,$*(1DFFRUGLQJWRWKHPDQXIDFWXUHU¶VSURFHGXUH51$VDPSOHVZHUe digested with DNase 128 
(Invitrogen) to remove any residual DNA. Total RNA (2 µg) was used for reverse transcription 129 
(RT) using oligo(dT) as primers and Superscript II reverse transcriptase kit (Invitrogen, Inc., 130 
Carlsbad, CA) according to the manufacturer¶V instructions. The primers used for the mRNA 131 
quantitation were p27 (F) 5-CGTCAAACGTAAACAGCTCG-3 and p27 (R)- 5-132 
CATTCCATGAAGTCAGCGAT-3, ORF50 (F)- 5-CAAACCCCATCCCAACAT-3 and ORF50 133 
(R)- 5-AGTAATCACGGCCCCTT-3, GAPDH (F) - 5-CCATGGAGAAGGCTGGGG-3 and 134 
GAPDH (R)- 5-CAAAGTTGTCATGGATGACC-3. These target genes were amplified using 135 
the iQ SYBER green real time master mix (BioRad) in a BioRad iCyclerIQ thermocycler. All 136 
reactions were performed in triplicate using the following conditions: 50°C for 2 min, 95°C for 137 
10 min, 40 cycles of 95°C for 15 sec and 60°C for 1 min. Melting-curve data for all the samples 138 
were obtained to ensure specific amplification. All reactions were performed in triplicate and 139 
included no-template controls for each gene. The experiments were repeated 2 times using 140 
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samples in triplicate. Relative gene expression was calculated using delta-delta-CT method (33). 141 
For calculating relative mRNA levels, the CT (threshold cycle) value of each gene was 142 
normalized to the CT value of GAPDH, and the normalized CT values from samples were 143 
compared to those of the control samples (untreated). 144 
Immunoprecipitation and immunoblot analysis. Total cell lysates for immunoprecipitation 145 
and western blotting were prepared in radioimmunoprecipitation assay buffer (RIPA) (50 mM 146 
Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1% NP-40) supplemented with protease and 147 
phosphatase inhibitor cocktail (Pierce). The lysates were kept in ice for 30 min with occasional 148 
vortexing. Finally, the lysates were centrifuged for 15 min at 13,000 x g at 4°C and the 149 
supernatant was collected. Cytosolic and nuclear proteins were extracted from TRExBJABRta 150 
cells using Sigma-&HO/\WLF NuCLEAR([WUDFWLRQ Kit XVLQJPDQXIDFWXUHU¶VSURWRFROThe 151 
protein concentration was measured using a BCA protein kit (Pierce, Rockford, IL). For 152 
immunoprecipitation, equal amount of lysate from each treatment was precleared with 20 µl of 153 
Protein A/G Sepharose (1hr, 4°C). Five percent of the precleared lysate was saved as input 154 
control and total amount of p27 was captured by incubating with 2 µg of anti-p27 (SC-1641; 155 
Santa Cruz) antibody overnight at 4°C. Immune complexes were captured with 30 µl of a 1:1 156 
mixture of Protein-A and Protein-G Sepharose beads (Pierce, Rockford, IL) for 2 hrs. The beads 157 
were then pelleted and washed three times with ice-cold RIPA buffer. The immunoprecipitated 158 
proteins were eluted by heating in 2X sample buffer and subjected to immunoblotting. 159 
For immunoblotting, equal amounts of total proteins (40 µg) were separated by sodium 160 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and subsequently transferred to 161 
nitrocellulose membrane using standard methods. After blocking with 5% non-fat dry milk in 162 
Tris-buffered saline (TBS) (20 mM Tris pH-7.4, 137 mM NaCl) containing 0.01% Tween-20 163 
(TBST) for 1 hr, the membrane was incubated with primary antibody overnight at 4°C. 164 
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Following washing with TBST three times, the membrane was incubated with horse peroxidase 165 
conjugated goat anti-rabbit/mouse secondary antibody (1:10000, Pierce) or infrared-tagged 166 
secondary antibodies (1:10000, Licor Inc., Lincoln, NE) for 30 min. Antibody binding was 167 
detected using SuperSignal West Dura Extended Duration Substrate kit (Pierce) or using an 168 
Odyssey imager. Image analysis and quantification of immunoreactive bands was performed 169 
using the Odyssey Infrared Imaging System application software (LiCor Inc., Lincoln, NE) or 170 
NIH ImageJ software.  171 
Following antibodies were used in the present study: anti-rabbit K-Rta antibody was a 172 
kind gift from Dr Izumiya (UC Davis, California) and was used at a dilution of 1:5000. The anti-173 
rabbit p27 (SC-528), anti-mouse p27 (SC-1641), anti-rabbit p21 (SC-397), anti-rabbit Rb 174 
(pS807/pS811) (BD558389), anti-rabbit Cyclin A (SC-751), anti-mouse GAPDH (SC-32233), 175 
anti-mouse Ub (SC-8017), anti-rabbit Skp2 (H-435), anti pp27-T187 (Ab75908 ), anti-mouse 176 
TATA binding protein (Ab818), anti-PRXVHĮWXEXOLQ6&-5286) were used at 1:1000 dilution in 177 
TBST.  178 
Protein stability test. Exponentially growing TRExBJABRta cells were cultured in the presence 179 
of doxycycline (DOX) for 24 hrs. DOX treated and untreated cells were treated with 50 ȝg/ml 180 
cyclohexamide (CHX) (Sigma-Aldrich, St. Louis, MO). The cells were harvested at indicated 181 
time points after CHX treatment and cell lysates were subjected to Western blot analysis. Band 182 
intensities were quantitated using Odyssey 3.0 software provided by Odyssey imager (LiCor 183 
Inc., Lincoln, NE) and the half-life of p27 protein was calculated from the slope of the curve. 184 
Immunofluorescence assay. TRExBJABRta cells were treated with doxycycline for 48 hrs. The 185 
cells were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.2% Triton X-100 186 
in phosphate buffered saline (PBS) for 10 minutes, and blocked for 30 min with 2% bovine 187 
serum albumin (BSA) in PBS at room temperature (RT). After incubation with primary 188 
10 
 
antibodies [anti-p27 mouse monoclonal (BD) and anti-rabbit K-Rta] both at 1:250 dilution in 2% 189 
BSA for 2 hrs at RT, the cells were incubated with anti-mouse Alexa-Fluor-488 and anti-rabbit 190 
Alexa-Fluor-647 conjugated secondary antibodies (1:1000) for 1 hour at RT. This was followed 191 
by three washes with PBS. The last wash contained 4',6-diamidino-2-phenylindole (DAPI) 192 
(Calbiochem) to counterstain nuclei. The localization of K-Rta/p27 and DAPI stained nuclei 193 
were visualized by confocal microscopy. 194 
Lentivirus-based shor t hairpin RNAs (shRNA) knockdown of p27. To establish p27 195 
knockdown cell line, plasmids encoding p27 shRNA (1 and 2) and scrambled negative control 196 
shRNA (1 and 2) were purchased from Origene and were transfected into TRExBJABRta cells 197 
using the Nucleofector kit T from Lonza (Walkersville, MD) according to thHPDQXIDFWXUHU¶V198 
procedure (Program- G-016). The transfected cells were selected with puromycin (1 µg/ml) for 3 199 
weeks.  200 
Lentivirus vector  expressing full length K-Rta, virus production and transduction of 201 
HMVEC cells. To generate a lentiviral vector expressing KSHV full length Rta, the coding 202 
sequence was cloned into pLVX-AcGFP1 (Clontech). The VSV-G-pseudotyped lentiviral 203 
particles were produced by transient cotransfection of 293T cells as described (34). Briefly, 5-6 204 
x106 HEK293T cells were co-transfected with 18 µg of K-Rta expressing transfer vector (pLVX-205 
Rta), 12 µg packaging vector psPAX2, and 6 µg of envelope vector pHEF-VSVG per 10 cm 206 
diameter plate at a 3:2:1 mass ratio by using standard calcium phosphate co-precipitation 207 
method. Eight hours post-transfection the media was replaced with DMEM supplemented with 208 
10% FBS. The medium containing the virus was harvested 48 hours post-transfection, filtered 209 
through 0.45 µm pore filter and concentrated by ultracentrifugation at 4°C for 2 hrs at 25,000 210 
rpm with T-865 rotor (Sorvall). Pellets were gently resuspended in DMEM and kept over-night 211 
at 4°C. The viral titers of concentrated pseudotyped lentiviruses were determined by transducing 212 
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3×105 293T cells seeded in one well of a 6-well plate in 4 ml of medium containing 8 ȝJPO of 213 
polybrene (Sigma). The media was replaced after 6 hrs. After 48 hours the number of cells 214 
expressing GFP was determined using flow cytometry. The viral titers were calculated using the 215 
formula: N×M / V where N is the number of target cells used for infection, M is % GFP 216 
expressing cells, and V is the volume of concentrated virus used in ml. 217 
Statistical Analysis. All data analysis was done using SPSS software (v11). Comparison of 218 
mean number of cells was done using Student¶V t-test. All p-values 0.05 were considered 219 
VLJQL¿FDQW  220 
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Results 221 
Expression of K-Rta induces cell cycle ar rest in G1 phase: Earlier investigations have 222 
reported that TPA-induced reactivation of KSHV results in cell cycle arrest in G1 phase of the 223 
treated cells and implicated early-lytic gene product K-bZIP for the induction of cell cycle arrest 224 
(17). Indeed TPA treatment of asynchronously growing BC3 cells (KSHV positive latent B-cell 225 
line) resulted in a marked increase of cells in the G1 fraction at 24 hrs after treatment, from 37% 226 
(before treatment) to 56.5%. This increase in proportion of cells arrested in G1 phase was also 227 
noted after TPA treatment of another KSHV positive latent B-cell line, Cro6, with a significant 228 
increase from 55.6% (before treatment) to 70.5% at 24 hrs post treatment. However TPA 229 
induced G1 arrest was not observed in KSHV negative control B-cell line DG75, at 24 hrs post 230 
TPA treatment (Fig. 1). These results confirmed previous findings that KSHV lytic reactivation 231 
arrests naturally infected B cells in G1 phase. 232 
Since G1 arrest is favored after lytic replication, we sought to investigate whether any 233 
other immediate early genes besides K-bZIP was involved in cell cycle arrest. We hypothesized 234 
that K-Rta being the central regulator of viral lytic cycle and one of the very first genes to be 235 
transcribed following reactivation may work in concert with K-bZIP to arrest cell cycle in G1 236 
phase. To investigate K-5WD¶VUROHLQFHOOF\FOHUHJXODWLRQZHutilized TRExBJABRta cells in 237 
which myc-tagged full length K-Rta gene is integrated into the chromosomal DNA under the 238 
control of a tetracycline-inducible promoter. Asynchronously growing exponential cultures of 239 
TRExBJAB (Control) and TRExBJABRta were synchronized in G0/G1 phase by serum 240 
starvation. The cells were released from growth arrest with the addition of medium containing 241 
10% serum along with doxycycline. We then quantitated the fraction of cells in different phases 242 
of cell cycle by flow cytometry at 24, 48 and 72 hrs post Dox treatment for both TRExBJAB and 243 
TRExBJABRta cells. The fraction of cells arrested in G0/G1 phase after 24 hrs of serum 244 
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starvation treatment was about 53% for both cell lines. Serum starvation for extended time was 245 
avoided as it affected cell viability. The cell cycle profiles of both cell lines were similar 246 
following release from serum starvation without Dox treatment and showed enrichment of cells 247 
in S phase over time (Data not shown). Interestingly cell cycle profile clearly showed a 248 
significant increase in the number of cells arrested at G1 phase in TRExBJABRta cells compared 249 
to control TRExBJAB cells at 48 hrs (p=0.006) and 72 hrs (p<0.001) post Dox treatment (Fig. 250 
2A). In contrast, there were more cells in S phase for TRExBJAB cells after 48 and 72 hr of Dox 251 
treatment, demonstrating that doxycycline alone has little or no effect on cell cycle progression 252 
following the release of cell cycle arrest in the absence of K-Rta. A significant arrest in G1 phase 253 
was also noted for Dox treated TREx293Rta cells at 72 hrs post treatment compared to untreated 254 
cells (p <0.001) (Fig. 2B) further supporting the data observed in BJAB cells. These results 255 
clearly show that the expression of K-Rta alone can induce cell cycle arrest in G1 phase.  256 
K-Rta expression led to a decrease in phosphorylated Rb and a parallel increase in p27kip1 257 
protein  levels: To explore the underlying mechanism of K-Rta mediated cell cycle arrest, the 258 
expression kinetics of key cell cycle regulators were analyzed by western blotting. Whole cell 259 
lysates were prepared from Dox treated and untreated TRExBJAB and TRExBJABRta cells. 260 
First we investigated the phosphorylation status of Retinoblastoma (Rb) protein, a critical 261 
negative regulator of the cell cycle that undergoes differential phosphorylation during the cell 262 
cycle (35). In early G1 phase Rb is largely dephosphorylated and bound to E2F family of 263 
transcriptional factors, forming a repressor complex. However, upon phosphorylation by 264 
Cdk4/6/cyclin D complex during early G1 phase and further by Cdk2/cyclin E during late G1 265 
phase, Rb dissociates from E2F, thus activating the expression of proteins needed for S-phase 266 
entry and progression (35). We examined the status of Rb phosphorylation using an antibody that 267 
recognizes Rb phosphorylated at Ser807/Ser811. These sites are the target sites of Cdk4/6/cyclin 268 
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D complex during G1 phase. Induction of K-Rta in TRExBJABRta cells resulted in a significant 269 
decrease in the phosphorylated levels of Rb, most notably at 48 and 72 hrs post Dox treatment 270 
(Fig. 3A). The results were markedly different in Dox untreated TRExBJABRta, which 271 
displayed a significant increase in the levels of phosphorylated Rb in a time dependent manner 272 
that reached peak expression by 48 hrs, indicating that most of these cells were actively 273 
progressing through the cell cycle. In control TRExBJAB cells, the levels of phosphorylated Rb 274 
increased in a time dependent manner following release from cell cycle arrest, irrespective of 275 
Dox treatment suggesting that Dox treatment alone did not affect the normal cell cycle 276 
progression. Cyclin A is useful marker for S phase whose expression increases during cell cycle 277 
progression (36). Cyclin A expression in both cell lines with or without Dox treatment followed 278 
the expression kinetics similar to phosphorylated Rb.  279 
 Since the activities of G1 cyclin-CDK complexes are mainly regulated by Cip/Kip family 280 
of Cyclin dependent kinase inhibitors (CDKIs), we aimed to evaluate the expression profile of 281 
p21 and p27, two central regulators of cell cycle progression that inhibit a broad range of cyclin 282 
Cdk complexes. The levels of p27 significantly increased over time in Dox treated 283 
TRExBJABRta cells but the kinetics of p27 protein accumulation lagged by about 24 hrs 284 
following the expression of Rta in TRExBJABRta cells, reaching maximum levels at 48 hrs 285 
(~5X above background) whereas in untreated cells, p27 levels decreased in a time dependent 286 
manner. In TRExBJAB cells, the expression kinetics of p27 was similar in both Dox treated or 287 
untreated cells and was consistent with those described for cells entering S phase following cell 288 
cycle arrest in G1 phase. The levels of p21 remained largely unchanged during the course of 289 
experiment for both cell lines irrespective of Dox treatment. Since p21 is a direct transcriptional 290 
target of p53, we also investigated the expression levels of p53 and found no significant change 291 
in the relative levels of p53 in both cell lines with or without Dox treatment (data not shown). 292 
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These results demonstrated that K-Rta-mediated cell cycle arrest in BJAB cells does not involve 293 
p21 and is associated with a decrease in Rb phosphorylation and a parallel increase in p27 levels.  294 
We also examined the expression of p27 in TPA treated BC3 cells and found that p27 295 
levels increased in a time dependent manner following reactivation (Figure 3B). This increase in 296 
p27 levels was not observed in TPA treated DG75 cells. Although this increase in p27 levels in 297 
TPA treated BC3 cells does not directly implicate K-Rta but it does show that cell cycle arrest 298 
during reactivation of KSHV from a latently infected B cell line is associated with an increase in 299 
p27 levels. 300 
To ensure that K-Rta mediated up regulation of p27 in BJAB cell line was not a cell type 301 
specific effect, we transiently transfected or transduced K-Rta in DG75, Vero cells and HMVEC 302 
cells respectively and checked the levels of p27 at 36 hours post-transfection/transduction by 303 
western blotting (Figure 3C) while the cells were actively growing at log phase. We found 304 
increased levels of p27 in cells that were transfected or transduced with K-Rta compared to cells 305 
that were transfected/transduced with vector or control virus. These results suggest that increase 306 
in p27 levels following K-Rta expression is not unique to BJAB cells. 307 
K-Rta does not affect p27 at the transcr iptional level: Since K-Rta is a transcriptional factor 308 
and has the ability to regulate the expression of cellular genes (37); we investigated the 309 
possibility whether the increased level of p27 in K-Rta expressing cells is due to transcriptional 310 
up regulation of p27 by K-Rta. Real time PCR was carried out with RNA samples extracted from 311 
Dox treated and untreated cells. As shown in figure 4A, the level of p27 mRNA after 312 
normalization with GAPDH showed no significant difference before and after K-Rta induction. 313 
The data suggest that the up regulation of p27 in K-Rta expressing cells is not due to increased 314 
p27 mRNA expression. These results were also supported by increased p27 levels observed in 315 
cells transiently transfected with K-Rta lacking the transactivation domain, suggesting that K-Rta 316 
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is not directly acting on p27 at the transcriptional level or the ability of K-Rta to upregulate p27 317 
is independent of its transactivation function (Fig. 4B). 318 
K-Rta expression results in stabilization of p27: Since p27 is mainly regulated at the post- 319 
translational level via the ubiquitin-proteasome pathway (38, 39), we examined the effect of K-320 
Rta on the half-life of p27. Protein synthesis was blocked in K-Rta expressing BJAB cells by 321 
cycloheximide and p27 protein levels were quantitated at various time intervals by 322 
immunoblotting (Fig. 5A). As a control, we also followed p27 levels in Dox untreated 323 
TRExBJABRta cells. In control cells, the half-life of p27 was found to be approximately 4.1 hrs 324 
but in K-Rta expressing cells the half-life of p27 increased to approximately 7.3 hrs. The data 325 
suggest that upregulation of p27 in K-Rta expressing cells is most likely mediated by changes in 326 
protein stability. Next, we investigated the possibility whether reduced poly-ubiquitination of 327 
p27 in K-Rta expressing cells is responsible for increased levels of p27. Poly-ubiquitination of 328 
the p27 was assessed by immunoprecipitating p27 from Dox treated and untreated 329 
TRExBJABRta cells followed by immunoblotting (Fig. 5B). As expected, there was an increase 330 
in p27 levels in K-Rta expressing cells in both lysate and immunoprecipitated lanes, however we 331 
detected decreased levels of ubiquitinated p27 in Dox-treated TRExBJABRta cells as evidenced 332 
by a reduction of the smear of high molecular weight p27 bands as compared to the uninduced 333 
Dox lane. These results suggest that the expression of K-Rta increases p27 stability by inhibiting 334 
the poly-ubiquitination and subsequent proteasomal degradation. 335 
K-Rta promotes nuclear  localization of p27: The activity of p27 is also regulated by its 336 
subcellular localization as it shuttles between nucleus and cytoplasm during the cell cycle (40). 337 
p27 is exclusively nuclear during G0/G1 phase but is exported to the cytoplasm in response to 338 
proliferating signals. Since the subcellular localization of p27 is inherently linked to the 339 
regulation of p27 activity, we determined whether K-Rta is modulating the subcellular 340 
17 
 
localization of p27. The localization of endogenous p27 was investigated in Dox treated and 341 
untreated TRExBJABRta cells by indirect immunofluorescence assay. Figure 6A shows a 342 
representative field of immunostaining. As expected, intense staining suggesting higher p27 343 
expression levels were observed in most K-Rta expressing cells. Further, the staining for p27 was 344 
predominantly nuclear and colocalized with K-Rta. In most of the untreated TRExBJABRta 345 
cells, the staining for p27 was less intense and mostly diffuse. In order to confirm the effects of 346 
K-Rta on p27 localization observed in immunofluorescence assay, we performed cell 347 
fractionation to determine the levels of p27 in nuclear and cytosolic extracts of untreated and 348 
treated TRExBJABRta by western blot (Fig. 6B). We found a significant fraction of p27 in the 349 
nuclear extracts (normalized to the total p27 levels) of K-Rta expressing BJAB cells (43% vs. 350 
14%) compared to the control cells. These results demonstrate that in addition to increased 351 
stability of p27, modulation of the intracellular localization of p27 also occurred in K-Rta 352 
induced G1 arrest.  353 
K-Rta induced cell cycle ar rest coincides with down regulation of Skp2: Multiple 354 
degradation pathways that regulate p27 protein levels have been characterized in recent years 355 
(39). One of the best-understood pathways for degradation of p27 is mediated by SCF/Skp2 356 
complex in late G1 phase and early S phase (41). CDK2-dependent phosphorylation at T187 357 
targets p27 to SCF/ Skp2 complex for ubiquitin-dependent degradation (42). CDK2-dependent 358 
phosphorylation at T187 and binding of phosphorylated p27 to Skp2 are both considered rate-359 
limiting steps for p27 ubiquitination and subsequent degradation (43, 44). We examined both 360 
these events to better define the mechanism of K-Rta mediated up regulation of p27. Figure 7 361 
shows the kinetics of Spk2 and p27 phosphorylated at T187 from Dox treated and untreated 362 
TRExBJABRta cells at various time intervals following release of cell cycle arrest. Skp2 levels 363 
decreased over time with kinetics that parallel increase in the levels of p27 in K-Rta expressing 364 
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cells. In Dox untreated TRExBJABRta cells, the kinetics was opposite with gradual 365 
accumulation of Skp2 over time. In K-Rta expressing cells, there was a decrease in the level of 366 
p27 phosphorylation at T187 and a parallel increase in the total p27 levels. However, in Dox 367 
untreated cells the level of phosphorylated p27 at T187 gradually increased over time with a 368 
parallel decrease in p27 levels as expected. These results suggest that K-Rta mediated up 369 
regulation of p27 is most likely a Skp2 dependent event and T187 is the key phosphorylation site 370 
targeted.  371 
Knock down of p27 expression by shRNAs mitigates K-Rta induced cell cycle ar rest. The 372 
data above strongly suggest that K-Rta induced cell cycle arrest involved impaired degradation 373 
of p27 by Skp2 resulting in accumulation of p27 in the nucleus. To conclusively prove that the 374 
observed accumulation of p27 had the causal effect on the cell cycle arrest or is directly 375 
responsible for K-Rta mediated cell cycle arrest, we knocked down p27 expression in 376 
TRExBJABRta cell line by stably expressing shRNAs against p27. Western blot analysis of Dox 377 
treated TRExBJABRta cell lines expressing shRNA against p27 showed efficient but incomplete 378 
knock down of p27 expression (~80% in both clones 1 and 2) (Fig. 8A). TRExBJABRta cell 379 
lines expressing control shRNAs (Clone 1 and 2) showed no significant reduction in the levels of 380 
p27 compared to the parent TRExBJABRta cell line. Next we quantitated cells in G1 phase from 381 
TRExBJABRta cells expressing these shRNAs after release from mitotic arrest and treatment 382 
with Dox. The results from FACS analysis showed that the down regulation of p27 by shRNA 383 
results in a significant decrease in K-Rta induced G1 arrest, ~60% in G1 phase compared to 384 
~70% cells in G1 phase in parent TRExBJABRta cells or TRExBJABRta cells stably expressing 385 
control shRNAs (Fig. 8B). We did not observe total abrogation of cell cycle arrest in G1 phase in 386 
TRExBJABRta cells expressing shRNA against p27 but we noticed a significant decrease of 387 
cells in G1 phase compared to TRExBJABRta cells expressing control shRNA. The data suggest 388 
19 
 
that the accumulation of p27 observed in K-Rta expressing cells contributes to cell cycle arrest at 389 
G1.   390 
20 
 
Discussion 391 
Our study demonstrates that KSHV encoded immediate early gene K-Rta induces cell 392 
cycle arrest in G0/G1 phase in an inducible B-cell line model. Consistent with G1 arrest, K-Rta 393 
mediated cell cycle arrest was associated with a decrease in the protein levels for cyclin A and 394 
phosphorylated Rb, both markers of S phase progression. Importantly, our results establish p27, 395 
a critical cyclin-dependent kinase inhibitor (CDKI) as a key player in K-Rta mediated cell cycle 396 
arrest. The central role of p27 in K-Rta mediated G1 arrest is supported by shRNA knockdown 397 
of p27, which significantly overrode the cell cycle arrest in K-Rta expressing cells. Since the 398 
knockdown of p27 did not completely abolish K-Rta mediated G1 arrest, we cannot exclude the 399 
possibility that K-Rta may also be functioning through other pathways that could contribute to 400 
cell cycle arrest. 401 
Our finding that K-Rta arrests cells in G0/G1 phase is in general agreement with recent 402 
studies that investigated the role of EBV encoded Rta (E-Rta) in cell cycle regulation (18). The 403 
expression of inducible E-Rta in 293 and nasopharyngeal carcinoma (NPC) derived cells resulted 404 
in G1 arrest (18, 19) which was associated with elevated levels of p21 and p27. However, we did 405 
not notice any significant changes in the expression of p21 in K-Rta expressing cells. It is 406 
possible that E-Rta and K-Rta may have evolved diverse mechanisms to arrest cell cycle in G1 407 
phase or these diverse pathways could be due to the different cellular contexts used in the 408 
experiments. It is interesting to note that K-Rta mediated increase in p27 levels was not at the 409 
transcriptional level and was independent of K-5WD¶VWUDQVDFWLYDWLRQDELOLW\7KHWUDQVDFWLYDWLRQ410 
function of several herpesviral immediate early genes including Zta, IE2 and ICP0 was found to 411 
be dispensable for cell cycle arrest (25, 45-47). Instead, the ability to arrest cell cycle was 412 
mapped to key motifs that are involved in protein-protein interactions like the bZIP domain of E-413 
Zta and RING finger domain for ICP0 (25, 45). These studies suggest that the transactivation 414 
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function of immediate early genes may be less important for mediating cell cycle arrest than 415 
direct interactions with key cell cycle regulators. 416 
In normal cells, p27 levels are maximal in quiescence but falls rapidly as the cells 417 
progress from G1 to S phase. p27 is a short-lived protein and its levels are mainly regulated by 418 
post-translational proteolytic degradation (39, 48). In the late G1 phase, degradation of p27 is 419 
mediated by SCF/Skp2 E3 ubiquitin ligase complex that requires phosphorylation of p27 at T187 420 
residue by cyclin E,A/ CDK2 complex (49). The phosphorylation at T187 creates a recognition 421 
site for Skp2 complex, which induces p27 poly-ubiquitination and subsequent degradation by the 422 
proteasome (41-43). The data presented here demonstrate that p27 was more stable in K-Rta 423 
expressing cells. This finding was also supported by decreased poly-ubiquitination of p27 424 
observed in K-Rta expressing cells. It is noteworthy that p27 degradation involves both Skp2-425 
dependent and -independent proteosomal degradation pathways (39). We have focused on Skp2-426 
dependent proteosomal pathway, as it is the best-characterized and most potent degradation 427 
pathway that determines p27 stability. It remains to be clarified whether K-Rta mediated 428 
stabilization of p27 also involve another degradation pathway besides Skp2-dependent pathway 429 
that would function independently of T187 phosphorylation. 430 
Based on our results, we hypothesize that there are at least three non-mutually exclusive 431 
possibilities by which K-Rta can induce cell cycle arrest, as summarized in Figure 8. First, K-Rta 432 
may sequester p27 in the nucleus to prevent its export to the cytoplasm by direct or indirect 433 
interaction. The localization of p27 seems to be finely regulated during G1 progression (39). To 434 
act as a cell cycle inhibitor, p27 must be localized in the nucleus, whereas its cytoplasmic export 435 
allows cell cycle progression. In our study we observed the accumulation of p27 in the nucleus 436 
of K-Rta expressing cells, but it is difficult to resolve whether K-Rta is directly modulating the 437 
subcellular localization of p27 or the nuclear accumulation of p27 is an indirect consequence of 438 
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K-Rta mediated cell cycle arrest. The second possibility is that K-Rta may induce or repress the 439 
expression of any upstream kinase or phosphatase, which may regulate the phosphorylation of 440 
p27. Several key phosphorylation sites have been characterized in recent years including S10, 441 
T157 and T198 that determine p27 stability and subcellular localization (39). The third 442 
possibility is that K-Rta may directly or indirectly interact with SCF/Skp2 complex to disrupt the 443 
binding between p27 and Skp2, which targets p27 for subsequent proteosomal degradation. Since 444 
K-Rta has been shown to possess E3 ubiquitin ligase activity, the last scenario becomes 445 
particularly interesting if Skp2 is identified as a target for K-Rta-mediated proteosomal 446 
degradation (50). In that case p27 will escape Skp2 mediated proteosomal degradation and would 447 
accumulate in the nucleus. We were able to co-immunoprecipitate over expressed tagged 448 
versions of K-Rta and Skp2 in transiently transfected 293T cells (Data not shown), however our 449 
effort to detect this interaction in vivo under physiologically relevant conditions was 450 
unsuccessful. It is plausible that the interaction between K-Rta and Skp2 is transient in nature 451 
and/or very weak.  452 
Recent research suggests that KSHV lytic reactivation is tightly linked to B-cell terminal 453 
differentiation (51). KSHV remains latent in a not very well characterized B-cell compartment 454 
until B cells differentiate into plasma cells. This terminal differentiation provides the 455 
physiological lytic switch through plasma cell transcription factor X box binding protein 1 456 
(XBP-1s). Thus, KSHV like EBV reactivates by exploiting the terminal differentiation pathway 457 
of latently infected B cells. In most cell lineages, final differentiation is associated with loss of 458 
proliferation and cell cycle arrest in G1 phase (52). During the differentiation process, the 459 
expression of various CDKIs including p27 is up regulated. Strong evidence for a role of p27 in 460 
differentiation programs comes from studies in mice lacking p27, which shows altered 461 
differentiation program in various tissues (53-55). It would be interesting to investigate whether 462 
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K-Rta mediated up-regulation of p27 following lytic reactivation also plays a role in 463 
differentiation of B cells besides cell cycle arrest.  464 
An issue that remains to be resolved is the experimental validation of the hypothesis of 465 
the presumed benefit of cell cycle arrest during KSHV or in general herpesvirus lytic replication. 466 
Most studies including ours have investigated the role of herpesviral immediate early genes in 467 
cell cycle regulation in an over expressed system. Experimental validation in the context of 468 
normal viral infection setting proves to be a challenging endeavor, most likely because of 469 
temporal and ephemeral nature of cell cycle arrest. In case of KSHV, it has been shown that 470 
following K-Rta induction there is a substantial increase in the expression of vCyclin and LANA 471 
proteins, both of which have the potential to accelerate cell cycle progression modulating Rb-472 
E2F pathway. Clearly, more work is needed to obtain a comprehensive understanding of cell 473 
cycle regulation in herpesvirus lytic replication. 474 
In summary our results demonstrate that KSHV encoded K-Rta is another player besides 475 
K8 that participate in arresting host cells in G1 phase following viral reactivation. K-Rta 476 
mediated cell cycle arrest was associated with stabilization and increased nuclear accumulation 477 
of p27. Our study has revealed a discrete functional role for K-Rta in host cell cycle regulation, 478 
which is independent of its function as a major viral transcriptional factor.  479 
24 
 
Acknowledgements 480 
This work was supported in part by the Public Health Service grants CA-75903, P20 481 
RR15635 and P30 GM103509 from the National Institutes of Health.  482 
We would like to thank Dr. Levon Abrahamyan for his help with confocal microscopy 483 
and Danielle Shea for help with flow cytometry. We also thank Dr. J. U. Jung at the University 484 
of Southern California for providing RTA-inducible BJAB cell line, Dr Luwen Zhang at the 485 
University of Nebraska, Lincoln for DG75 and Cro6 cell lines and Dr. Izumiya at UC Davis for 486 
Rta polyclonal serum.  487 
25 
 
References 488 
1. Mesr i EA, Cesarman E, Boshoff C. 2010. Kaposi's sarcoma and its associated 489 
herpesvirus. Nat Rev Cancer 10:707-719. 490 
2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-491 
associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based 492 
lymphomas. N Engl J Med 332:1186-1191. 493 
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper  J , Knowles DM, Moore PS. 494 
1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's 495 
sarcoma. Science 266:1865-1869. 496 
4. Soulier  J , Grollet L, Oksenhendler  E, Cacoub P, Cazals-Hatem D, Babinet P, 497 
d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-498 
associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 499 
86:1276-1280. 500 
5. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human 501 
biology and medicine. J Clin Invest 120:939-949. 502 
6. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller  G. 1998. A viral gene that 503 
activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl 504 
Acad Sci U S A 95:10866-10871. 505 
7. Lukac DM, Renne R, Kirshner  JR, Ganem D. 1998. Reactivation of Kaposi's sarcoma-506 
associated herpesvirus infection from latency by expression of the ORF 50 transactivator, 507 
a homolog of the EBV R protein. Virology 252:304-312. 508 
8. Gradoville L, Ger lach J , Grogan E, Shedd D, Nikiforow S, Metroka C, Miller  G. 509 
2000. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein 510 
26 
 
activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J 511 
Virol 74:6207-6212. 512 
9. Xu Y, AuCoin DP, Huete AR, Cei SA, Hanson LJ , Par i GS. 2005. A Kaposi's 513 
sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective 514 
for reactivation of latent virus and DNA replication. J Virol 79:3479-3487. 515 
10. Duan W, Wang S, Liu S, Wood C. 2001. Characterization of Kaposi's sarcoma-516 
associated herpesvirus/human herpesvirus-8 ORF57 promoter. Arch Virol 146:403-413. 517 
11. Deng H, Young A, Sun R. 2000. Auto-activation of the rta gene of human herpesvirus-518 
8/Kaposi's sarcoma-associated herpesvirus. J Gen Virol 81:3043-3048. 519 
12. Deng H, Chu JT, Rettig MB, Mar tinez-Maza O, Sun R. 2002. Rta of the human 520 
herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 521 
gene expression. Blood 100:1919-1921. 522 
13. Chen J , Ueda K, Sakakibara S, Okuno T, Yamanishi K. 2000. Transcriptional 523 
regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory 524 
factor gene. J Virol 74:8623-8634. 525 
14. Chang PJ , Shedd D, Gradoville L, Cho MS, Chen LW, Chang J , Miller  G. 2002. 526 
Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly 527 
activates the viral PAN and K12 genes by binding to related response elements. J Virol 528 
76:3168-3178. 529 
15. Bowser  BS, Morr is S, Song MJ, Sun R, Damania B. 2006. Characterization of 530 
Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta. 531 
Virology 348:309-327. 532 
27 
 
16. Salvant BS, For tunato EA, Spector  DH. 1998. Cell cycle dysregulation by human 533 
cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on 534 
cyclin transcription. J Virol 72:3729-3741. 535 
17. Izumiya Y, Lin SF, Ellison TJ , Levy AM, Mayeur  GL, Izumiya C, Kung HJ . 2003. 536 
Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct 537 
interaction with cyclin-CDK2 and induction of G1 growth arrest. J Virol 77:9652-9661. 538 
18. Huang SY, Hsieh MJ, Chen CY, Chen YJ , Chen JY, Chen MR, Tsai CH, Lin SF, 539 
Hsu TY. 2012. Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3sigma 540 
arrests cells at the G1/S transition by reducing cyclin E/CDK2 activity. J Gen Virol 541 
93:139-149. 542 
19. Chen YL, Chen YJ , Tsai WH, Ko YC, Chen JY, Lin SF. 2009. The Epstein-Barr virus 543 
replication and transcription activator, Rta/BRLF1, induces cellular senescence in 544 
epithelial cells. Cell Cycle 8:58-65. 545 
20. Flemington EK. 2001. Herpesvirus lytic replication and the cell cycle: arresting new 546 
developments. J Virol 75:4475-4481. 547 
21. Nishioka WK, Welsh RM. 1994. Susceptibility to cytotoxic T lymphocyte-induced 548 
apoptosis is a function of the proliferative status of the target. J Exp Med 179:769-774. 549 
22. Kawaguchi Y, Van Sant C, Roizman B. 1997. Herpes simplex virus 1 alpha regulatory 550 
protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 551 
71:7328-7336. 552 
23. Hobbs WE, 2nd, DeLuca NA. 1999. Perturbation of cell cycle progression and cellular 553 
gene expression as a function of herpes simplex virus ICP0. J Virol 73:8245-8255. 554 
28 
 
24. Rodr iguez A, Jung EJ , Yin Q, Cayrol C, Flemington EK. 2001. Role of c-myc 555 
regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and 556 
p27 and cell growth arrest. Virology 284:159-169. 557 
25. Cayrol C, Flemington EK. 1996. The Epstein-Barr virus bZIP transcription factor Zta 558 
causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. 559 
EMBO J 15:2748-2759. 560 
26. Wu FY, Chen H, Wang SE, ApRhys CM, Liao G, Fujimuro M, Far rell CJ , Huang J , 561 
Hayward SD, Hayward GS. 2003. CCAAT/enhancer binding protein alpha interacts 562 
with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest 563 
during the Epstein-Barr virus lytic cycle. J Virol 77:1481-1500. 564 
27. Wu FY, Wang SE, Tang QQ, Fujimuro M, Chiou CJ , Zheng Q, Chen H, Hayward 565 
SD, Lane MD, Hayward GS. 2003. Cell cycle arrest by Kaposi's sarcoma-associated 566 
herpesvirus replication-associated protein is mediated at both the transcriptional and 567 
posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and 568 
p21(CIP-1). J Virol 77:8893-8914. 569 
28. Nakamura H, Lu M, Gwack Y, Souvlis J , Zeichner  SL, Jung JU. 2003. Global 570 
changes in Kaposi's sarcoma-associated virus gene expression patterns following 571 
expression of a tetracycline-inducible Rta transactivator. J Virol 77:4205-4220. 572 
29. Tr ivedi P, Takazawa K, Zompetta C, Cuomo L, Anastasiadou E, Carbone A, Uccini 573 
S, Belardelli F, Takada K, Frati L, Faggioni A. 2004. Infection of HHV-8+ primary 574 
effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV 575 
latency, altered phenotype, and increased tumorigenicity without affecting TCL1 576 
expression. Blood 103:313-316. 577 
29 
 
30. Shao R, Guo X. 2004. Human microvascular endothelial cells immortalized with human 578 
telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem 579 
Biophys Res Commun 321:788-794. 580 
31. Wen HJ , Yang Z, Zhou Y, Wood C. 2010. Enhancement of autophagy during lytic 581 
replication by the Kaposi's sarcoma-associated herpesvirus replication and transcription 582 
activator. J Virol 84:7448-7458. 583 
32. Riccardi C, Nicoletti I. 2006. Analysis of apoptosis by propidium iodide staining and 584 
flow cytometry. Nat Protoc 1:1458-1461. 585 
33. Livak KJ , Schmittgen TD. 2001. Analysis of relative gene expression data using real-586 
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. 587 
34. Tiscornia G, Singer  O, Verma IM. 2006. Production and purification of lentiviral 588 
vectors. Nat Protoc 1:241-245. 589 
35. Giacinti C, Giordano A. 2006. RB and cell cycle progression. Oncogene 25:5220-5227. 590 
36. Resnitzky D, Hengst L, Reed SI. 1995. Cyclin A-associated kinase activity is rate 591 
limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell 592 
Biol 15:4347-4352. 593 
37. Chang H, Gwack Y, Kingston D, Souvlis J , Liang X, Means RE, Cesarman E, Hutt-594 
Fletcher  L, Jung JU. 2005. Activation of CD21 and CD23 gene expression by Kaposi's 595 
sarcoma-associated herpesvirus RTA. J Virol 79:4651-4663. 596 
38. Pagano M, Tam SW, Theodoras AM, Beer -Romero P, Del Sal G, Chau V, Yew PR, 597 
Draetta GF, Rolfe M. 1995. Role of the ubiquitin-proteasome pathway in regulating 598 
abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685. 599 
39. Susaki E, Nakayama KI. 2007. Multiple mechanisms for p27(Kip1) translocation and 600 
degradation. Cell Cycle 6:3015-3020. 601 
30 
 
40. Reynisdottir  I, Massague J . 1997. The subcellular locations of p15(Ink4b) and 602 
p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 603 
11:492-503. 604 
41. Car rano AC, Eytan E, Hershko A, Pagano M. 1999. SKP2 is required for ubiquitin-605 
mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199. 606 
42. Tsvetkov LM, Yeh KH, Lee SJ , Sun H, Zhang H. 1999. p27(Kip1) ubiquitination and 607 
degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in 608 
p27. Curr Biol 9:661-664. 609 
43. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyr iakides TR, Rober ts JM. 610 
2001. A mouse knock-in model exposes sequential proteolytic pathways that regulate 611 
p27Kip1 in G1 and S phase. Nature 413:323-327. 612 
44. Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, 613 
Kitagawa M, Iemura S, Natsume T, Nakayama KI. 2004. Skp2-mediated degradation 614 
of p27 regulates progression into mitosis. Dev Cell 6:661-672. 615 
45. Lomonte P, Everett RD. 1999. Herpes simplex virus type 1 immediate-early protein 616 
Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the 617 
cell cycle. J Virol 73:9456-9467. 618 
46. Rodr iguez A, Armstrong M, Dwyer  D, Flemington E. 1999. Genetic dissection of cell 619 
growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J 620 
Virol 73:9029-9038. 621 
47. Wiebusch L, Hagemeier  C. 1999. Human cytomegalovirus 86-kilodalton IE2 protein 622 
blocks cell cycle progression in G(1). J Virol 73:9274-9283. 623 
48. Vervoor ts J , Luscher  B. 2008. Post-translational regulation of the tumor suppressor 624 
p27(KIP1). Cell Mol Life Sci 65:3255-3264. 625 
31 
 
49. Montagnoli A, Fiore F, Eytan E, Car rano AC, Draetta GF, Hershko A, Pagano M. 626 
1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric 627 
complex formation. Genes Dev 13:1181-1189. 628 
50. Yu Y, Wang SE, Hayward GS. 2005. The KSHV immediate-early transcription factor 629 
RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated 630 
degradation. Immunity 22:59-70. 631 
51. Wilson SJ , Tsao EH, Webb BL, Ye H, Dalton-Gr iffin L, Tsantoulas C, Gale CV, Du 632 
MQ, Whitehouse A, Kellam P. 2007. X box binding protein XBP-1s transactivates the 633 
Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell 634 
differentiation to KSHV reactivation from latency. J Virol 81:13578-13586. 635 
52. Kaldis P, Richardson HE. 2012. When cell cycle meets development. Development 636 
139:225-230. 637 
53. Durand B, Gao FB, Raff M. 1997. Accumulation of the cyclin-dependent kinase 638 
inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-639 
317. 640 
54. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono 641 
M, Khanam D, Hayday AC, Frohman LA, Koff A. 1996. Enhanced growth of mice 642 
lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732. 643 
55. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Hor ii I, Loh 644 
DY. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ 645 
hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720. 646 
 647 
 648 
  649 
32 
 
Figure Legends 650 
Figure 1.  KSHV reactivation following TPA treatment ar rests cells in G0/G1 phase: 651 
Asynchronously growing exponential cultures of BC3 and Cro6 (KSHV positive) and DG75 652 
(KSHV negative) cells were treated with TPA (20 ng/ml). At the indicated times post-TPA 653 
treatment, the cells were fixed, stained with propidium iodide (PI) and analyzed by flow 654 
cytometry. Cell cycle phase distribution was determined using ModFit LT version 2.0 software. 655 
Cell cycle profiles presented here are representative of two independent experiments. 656 
Figure 2.  K-Rta ar rests cells in G0/G1 phase: (A) Asynchronously growing exponential 657 
cultures of control cell line (TRExBJAB) and Rta inducible BJAB cell line (TRExBJABRta) 658 
were synchronized by serum starvation for 24 hours. Growth arrested cells were stimulated with 659 
medium containing 10% serum and doxycycline (Dox). At the indicated times post-Dox 660 
treatment, the cells were fixed, stained with propidium iodide (PI) and analyzed by flow 661 
cytometry. Cell cycle phase distribution was determined using ModFit LT version 2.0 software. 662 
Data represents the mean of three independent experiments. Errors bars represent SD for 663 
triplicate samples. A significant increase in the number of cells stuck at G0/G1 phase was noted 664 
in TRExBJAB vs TRExBJABRta at 48 hrs (p=0.006) and 72 hrs (p<0.001) post-Dox treatment. 665 
(B) Asynchronously growing exponential cultures of TREx293 Rta cells were treated with 666 
doxycycline. At 72 hrs post-Dox treatment, treated and untreated cells were fixed, stained with 667 
PI and cell cycle status was determined by flow cytometry as described above. A significant 668 
arrest in G1 phase was noted for Dox treated TREx293Rta cells at 72 hrs post Dox treatment 669 
compared to untreated cells (p<0.001). Cell cycle profiles presented here are mean of three 670 
independent experiments. Errors bars represent SD for triplicate samples.  671 
Figure 3.  K-Rta expressing cells have increased levels of p27kip1: (A) Asynchronously 672 
growing exponential cultures of control cell line (TRExBJAB) and Rta inducible BJAB cell line 673 
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(TRExBJABRta) were synchronized by serum starvation for 24 hours. Growth arrested cells 674 
were stimulated with medium containing 10% serum and doxycycline. Doxycycline treated or 675 
untreated TRExBJAB and TRExBJABRta cells were harvested and the expression kinetics of 676 
key cell cycle regulators were followed by immunoblotting at indicated times. GAPDH served as 677 
a loading control. The numbers below p27 band indicate the relative intensities of the p27 protein 678 
normalized to GAPDH protein. (B) Asynchronously growing DG75 (KSHV negative) and BC3 679 
(KSHV positive) cells were treated with TPA (20 ng/ml) for 24 and 48 hrs. The lysates were 680 
immunoblotted with antibodies as indicated. (C) DG75 and Vero cells were transiently 681 
transfected with either empty Flag vector or Flag Rta expression plasmid. Human Microvascular 682 
Endothelial Cells (HMVEC) cells were transduced with equal amounts of either control 683 
lentivirus or lentivirus expressing K-Rta. The cells were harvested after 36 hrs and the lysates 684 
were immunoblotted with antibodies as indicated. The values below the figure represent relative 685 
density of p27 bands normalized to that of GAPDH bands.  686 
Figure 4.  K-Rta does not affect p27 at the transcr iptional level:  (A) RNA was harvested 687 
from parallel samples collected at 0, 24, 48 and 72 hrs from doxycycline treated or untreated 688 
TRExBJAB and TRExBJABRta cells from the same experiment as described in Fig 2. The 689 
samples were subjected to quantitative real-time PCR analysis to detect the transcript levels of 690 
K-Rta, p27 and GAPDH. Each sample was tested in triplicate and representative data obtained 691 
from two independent experiments is shown. Relative gene expression was normalized to 692 
GAPDH expression and the fold change in the expression of each gene was calculated by using 693 
the delta-delta Ct method. (B) Schematic diagram depicting various domains of Rta protein. 694 
5X106 293-T cells were transiently transfected with 4 µg of either empty Flag vector, Flag vector 695 
expressing full length K-Rta (FL) or Flag vector expressing truncated K-Rta (1-527 AA). The 696 
cells were harvested 36 hrs post transfection and whole cell lysate was immunoblotted with anti-697 
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Flag antibody, anti-p27 antibody and anti-GAPDH antibody. LZ ± Leucine zipper, NLS ± 698 
Nuclear localization signal.  699 
Figure 5.  K-Rta affects p27 protein stability: (A) Stability test:  K-Rta inducible BJAB cell 700 
cultures (TRExBJABRtDZHUHWUHDWHGZLWKȝJPOF\FORKH[DPLGH&+;LQWKHDEVHQFHRU701 
presence of doxycycline (Dox) for indicated lengths of time (In hours). Cell lysates were 702 
subjected to Western blot analysis with indicated antibodies. The relative band intensity of p27 703 
(normalized to GAPDH) was plotted with respect to time after CHX addition. Gel images 704 
presented here are representative of three independent experiments. (B) Doxycyline treated and 705 
untreated (for 48 hrs) TRExBJABRta cells were pretreated with proteasome inhibitor MG132 706 
ȝ0EHIRUHKDUYHVWLQJ&HOOH[WUDFWVZHUHSUHSDUHGXQGHUGHQDWXULQJO\VLVFRQGLWLRQVDQG707 
p27 was immunoprecipitated (IP) from Dox treated and untreated TRExBJABRta cells. 708 
Immunoprecpitates were subjected to Western blot analysis using p27, Rta and GAPDH 709 
antibody. The same membrane was stripped and reprobed with anti-Ubiquitin (Ub) antibody. Gel 710 
images presented here are representative of three independent experiments. WB ± Western Blot.  711 
Figure 6.  K-Rta can promote nuclear  localization of p27: (A) TRExBJABRta cells were 712 
treated with doxycycline for 48 hrs. The Dox treated and untreated cells were fixed with 4% 713 
paraformaldehyde for 20 min, permeabilized with 0.2% Triton X-100 in PBS for 10 minutes, and 714 
blocked for 30 min with 2% bovine serum albumin (BSA) in PBS. After incubation with primary 715 
antibodies (anti-p27 and anti-Rta, both 1:250 dilution) in 2% BSA for 2 hrs at room temperature, 716 
the cells were incubated with anti-mouse Alexa-Fluor-488 and anti-rabbit Alexa-Fluor-647 717 
conjugated secondary antibodies (1:1000) for 1 hour at room temperature. The Rta and p27 718 
localization and DAPI stained nuclei were visualized by confocal microscopy. (B) Cytosolic and 719 
nuclear fractions were extracted from TRExBJABRta cells treated with doxycyline and subjected 720 
to western blotting with indicated antibodies. TATA binding protein (TBP) and Į-tubulin were 721 
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used as a nuclear fraction and cytosolic fraction loading control respectively. The bar graph on 722 
the right side shows percent of p27 quantitated in the nuclear fraction (normalized to total p27 723 
levels). Gel images presented here are representative of two independent experiments.  724 
Figure 7. K-Rta expressing cells have decreased levels of Skp2: TRExBJABRta cells were 725 
serum starved for 24 hours. Growth arrested cells were stimulated with medium containing 10% 726 
serum and doxycycline. At times indicated doxycycline treated and untreated cells were 727 
harvested and lysates were subjected to immunoblot analysis with indicated antibodies. GAPDH 728 
served as a loading control. Gel images presented here are representative of two independent 729 
experiments.  730 
Figure 8. Knock down of p27 expression by sh-RNAs attenuates K-Rta induced cell cycle 731 
ar rest: The parent cell line, TRExBJABRta cells or TRExBJABRta cells stably expressing 732 
control sh-RNA (clone #1 and #2) or sh-RNA against p27 (clone #1 and #2) were serum starved 733 
for 24 hrs. Growth arrested cells were stimulated with medium containing 10% serum and 734 
doxycycline. At 48 hrs post doxycycline treatment, the cells were harvested for flow cytometry 735 
and immunoblot analysis. (A) Whole cell lysates were subjected to immunoblot analysis with 736 
indicated antibodies. GAPDH served as a loading control. The numbers below p27 band indicate 737 
the relative intensities of the p27 protein normalized to GAPDH protein. (B) For flow cytometry, 738 
the cells were fixed, stained with propidium iodide and cell cycle phase distribution was 739 
determined using ModFit LT version 2.0 software. Data represents the mean ± SD of two 740 
independent experiments.  741 
Figure 9. A schematic diagram for  K-Rta mediated cell cycle ar rest in G0/G1 phase: 1, 2 742 
and 3 represent alternate possibilities elaborated in the discussion section by which K-Rta can 743 
induce cell cycle arrest. 744 
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